Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse Neurogranin ELISA Kit (AC3108)
Cat.#: ASET-1697
Specifications
Description Mouse Neurogranin ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Neurogranin concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.54 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15-240 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1289 Human Semaphorin 3E ELISA Kit (AC2700) Quantitative inquiry ASET-1312 Bovine Adiponectin ELISA Kit (AC2723) Quantitative inquiry ASET-2505 Rat Luteinizing Hormone ELISA Kit (AC3916) Quantitative inquiry ASET-2122 Human COMT ELISA Kit (AC3533) Quantitative inquiry ASET-1372 Human Bim ELISA Kit (AC2783) Quantitative inquiry ASET-1785 Porcine C Peptide ELISA Kit (AC3196) Quantitative inquiry ASET-1786 Human NK-1R ELISA Kit (AC3197) Quantitative inquiry ASET-1390 Mouse Clathrin Light Chain ELISA Kit (AC2801) Quantitative inquiry ASET-2072 Mouse GDF11 ELISA Kit (AC3483) Quantitative inquiry ASET-1187 Rat VAP1 ELISA Kit (AC2598) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket